Edition:
United Kingdom

Denali Therapeutics Inc (DNLI.OQ)

DNLI.OQ on NASDAQ Stock Exchange Global Select Market

21.12USD
21 May 2019
Change (% chg)

-- (--)
Prev Close
$21.12
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
130,492
52-wk High
$28.84
52-wk Low
$12.36

About

Denali Therapeutics Inc. is a biotechnology company. The Company is focused on the discovery and development of therapies for patients with neurodegenerative disease, including Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis (ALS) and others. The Company is developing a diversified portfolio of therapeuti... (more)

Overall

Beta: --
Market Cap(Mil.): $2,016.50
Shares Outstanding(Mil.): 95.48
Dividend: --
Yield (%): --

Financials

  DNLI.OQ Industry Sector
P/E (TTM): -- 97.03 53.45
EPS (TTM): -0.56 -- --
ROI: -8.38 7.44 11.71
ROE: -9.77 7.90 16.35

Earnings vs. Estimates